Truveta’s groundbreaking study analyzing real-world use of GLP-1 receptor agonist (GLP-1 RA) therapies in adults with overweight or obesity has published in JAMA Network Open, offering critical ...

and gastric inhibitory polypeptide drugs as of Wednesday, Jan. 1. The drugs can be used to prevent diabetes and to treat insulin resistance, metabolic syndrome or morbid obesity, according to a ...

Gut hormones that influence satiety, such as peptide YY (PYY ... the role of gut hormones in appetite change after Roux-en-Y gastric bypass. Le Roux et al. measured fasting and postprandial ...

Tirzepatide is one of a growing number of popular weight loss drugs that mimic the hormones GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide) to manage blood sugar levels ...

Thereafter stepwise isobaric distensions were performed with ongoing peptide infusion, and gastric sensation was scored. Conclusions: GLP-1 is a candidate physiological inhibitory regulator of fundus ...

“We are extremely excited to announce our second internal peptide-RI clinical development candidate, PD-29875, targeting CLDN18.2 for the potential diagnosis and treatment of gastric ...

It is secreted by gastric antral and pyloric glands and by Brunner's glands of the duodenum. TFF2 is found in high concentrations around sites of ulceration. It stimulates cell motility and is ...

Administration of oxytocin, a peptide that is known to be released during stress by the intracisternal area of the brain produces an inhibitory effect on acid secretion. Stress can also cause reduced ...